Susanna studied Molecular Science at the Friedrich-Alexander University in Erlangen. Molecular sciences is a cross-disciplinary field that studies molecular materials, structures and systems. Molecular sciences serve as a basis for scientific areas such as medicine, pharmacology, chemistry, bio-molecular engineering, molecular biology and physics. Masters in Molecular Sciences also involve aspects of scientific innovation and discovery, biochemistry and chemical engineering.
Further to her studies of Molecular Science, Susanna did doctoral studies in the field of Molecular Life Science. She investigated the interaction of plant viruses with different biochemical systems of plants, which are manipulated by the plant viruses to suppress the plant immune system. In connection with this research, Susanna spent some time abroad at the Greehey Distinguished Chair in Targeted Molecular Therapeutics at the UT Health San Antonio, Texas, USA and at the Shanghai Center for Plant Stress Biology in Shanghai, China.
After focussing on Molecular Life Science in her dissertation, she has gone back to her roots in HGF's chemistry group in Munich.
Herein, she is working in the field of material science, inorganic chemistry and metallurgy.
After her trainee patent attorney program her individual cross-disciplinary knowledge in science will make her an especially qualified patent attorney.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.